----

----

|  IDAHO                      |  82-0266517          |
|---------------------------------------|---------------------------|
|  (State or other jurisdiction of |  (I.R.S. Employer    |
|  incorporation or organization)  |  Identification No.) |

----

----

| PART I. CONSOLIDATED FINANCIAL INFORMATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |   |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Financial Statements. |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     Condensed Consolidated Balance Sheets |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     Condensed Consolidated Statements of Operations  |  4 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     Condensed Consolidated Statements of Cash Flows |  5 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     Notes to Condensed Consolidated Financial Statements |  6 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Management's Discussion and Analysis of Financial Condition and Plan of Operations |  15 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Quantitative and Qualitative Disclosures About Market Risk |  18 |
| Item 4T.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Controls and Procedures |  19 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |   |
| PART II. OTHER INFORMATION                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |   |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Legal Proceedings |  20 |
| Item 1A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Risk Factors |  20 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Unregistered Sales of Equity Securities and Use of Proceeds |  20 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DefaultsUpon Senior Securities |  20 |
| Item 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | (Removed) |  20 |
| Item 5.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Other Information |  21 |
| Item 6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Exhibits |  21 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |   |
| Signatures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |  22 |

----

|   | PART I.  CONSOLIDATED FINANCIAL INFORMATION |
|--------|-------------------------------------------------------|

| Item 1.   | FinancialStatements. |
|---------------------|----------------------|

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                    |   |   |                                                                                                   |
|--------------------------------------------------------------------------------------------------------------------|--------|--------|--------------------------------------------------------------------------------------------------------|
|                                                                                                               |   |   |                                                                                                   |
| CONSOLIDATED  BALANCE SHEETS                                                                             |   |   |                                                                                                   |
|                                                                                                               |   |   |                                                                                                   |
|                                                                                                               |   |   | September 30,                                                                                          |   | December 31, |   |
|                                                                                                               |   |   | 2010                                                                                                   |   | 2009 |   |
|                                                                                                               |   |   | (Unaudited)                                                                                            |   |   |   |
| ASSETS                                                                                                             |   |   |                                                                                                   |   |   |   |
| CURRENT ASSETS:                                                                                                    |   |   |                                                                                                   |   |   |   |
|       Cash and cash equivalents                                                      |   |   |  $           174,111                       |   |  $          59,110 |   |
|       Accounts Receivable                                                            |   |   | 19,500                                                                                                 |   |                      - |   |
|       Inventory, net                                                                 |   |   | 215,806                                                                                                |   |            203,158 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|         Total current assets                                               |   |   | 409,417                                                                                                |   |            262,268 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  FIXED ASSETS, NET                                                                                            |   |   | 163,960                                                                                                |   | 180,946 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  OTHER ASSETS                                                                                                 |   |   | 13,695                                                                                                 |   | 13,695 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|     Total assets                                                                               |   |   | $           587,072                                  |   |  $        456,909 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)                                                            |   |   |                                                                                                   |   |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  CURRENT LIABILITIES:                                                                                         |   |   |                                                                                                   |   |   |   |
|        Accounts payable and accrued expenses                                    |   |   |  $           410,035                       |   |  $     1,790,598 |   |
|         Current portion of note payable                                    |   |   | 30,836                                                                                                 |   | 30,836 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|         Total current liabilities                                          |   |   |               440,871            |   |         1,821,434 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|    LONG TERM NOTE PAYABLE                                                                           |   |   | 50,452                                                                                                 |   | 77,556 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|         Total liabilities                                                  |   |   |               491,323            |   |         1,898,990 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  COMMITMENTS AND CONTINGENCIES                                                                                |   |   |                                                                                                   |   |   |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  SHAREHOLDERS' EQUITY (DEFICIENCY):                                                                           |   |   |                                                                                                   |   |   |   |
|  Common stock, $.001 par value, 42,750,000 shares authorized;                                                 |   |   |                                                                                                   |   |   |
|         31,290,497 and 25,268,994 shares issued and outstanding            |   |   |                                                                                                   |   |   |   |
|          as of September 30, 2010 and December 31, 2009, respectively |   | 31,290 |                                                                                                   | 25,269 |   |
|  Additional paid-in capital                                                                                   |   |   | 12,377,439                                                                                             |   | 9,473,710 |   |
|  Deferred compensation                                                                                        |   |   |                (19,250)     |   |             (13,333) |   |
|  Accumulated deficit                                                                                          |   |   | (12,293,730)                                                                                           |   | (10,927,727) |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|         Total shareholders' equity (deficiency)                            |   |   |                 95,749 |   |        (1,442,081) |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |
|  Total liabilities and shareholders' equity (deficiency)                                                      |   |   |  $           587,072                       |   |  $        456,909 |   |
|                                                                                                               |   |   |                                                                                                   |   |   |   |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                          |
|--------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                     |   |   |   |   |   |   |   |
|  CONSOLIDATED STATEMENTS OF OPERATIONS                                                                              |
|                                                                                                                     |   |   |   |   |   |   |   |
|                                                                                                                     |   |   |   |   |   |   |   |
|                                                                                                                     |   Three Months Ended September 30, |   |   Nine Months Ended September 30, |
|                                                                                                                     | 2010 |   | 2009 |   | 2010 |   | 2009 |
|                                                                                                                     |   |   |   |   |   |   |   |
|                                                                                                                     |   |   |   |   |   |   |   |
| Revenues, net                                                                                                            |  $               69,000 |   |  $             300,393 |   |  $             185,401 |   |  $             431,333 |
|                                                                                                                     |   |   |   |   |   |   |   |
| Cost of goods sold                                                                                                       |                            - |   |                   23,209 |   | 17,048 |   |                   55,209 |
|                                                                                                                     |   |   |   |   |   |   |   |
| Gross profit                                                                                                             |                   69,000 |   |                 277,184 |   |                 168,353 |   |                 376,124 |
|                                                                                                                     |   |   |   |   |   |   |   |
| Costs and expenses:                                                                                                      |   |   |   |   |   |   |   |
|       General and administrative                                                           |                 450,881 |   |                 207,039 |   | 954,004 |   |                 516,918 |
|       Research and development                                                             |                 218,464 |   |                   65,249 |   | 574,208 |   |                 327,622 |
|                                                                                                                     |   |   |   |   |   |   |   |
|                 Total costs and expenses |                 669,345 |   |                 272,289 |   |              1,528,212 |   |                 844,540 |
|                                                                                                                     |   |   |   |   |   |   |   |
| Loss from operations                                                                                                     |               (600,345) |   |                     4,895 |   |            (1,359,859) |   |               (468,416) |
|                                                                                                                     |   |   |   |   |   |   |   |
| Other (expenses):                                                                                                        |   |   |   |   |   |   |   |
|       Interest income                                                                      |   |   |                            - |   | 6 |   |                            - |
|       Interest expense                                                                     |                   (1,858) |   |                   (2,608) |   | (6,151) |   |                   (8,352) |
|                                                                                                                     |   |   |   |   |   |   |   |
|               Total other expense                  |                   (1,858) |   |                   (2,608) |   |                   (6,145) |   |                   (8,352) |
|                                                                                                                     |   |   |   |   |   |   |   |
| NET LOSS                                                                                                                 |  $           (602,203) |   |  $                 2,288 |   |  $        (1,366,004) |   |  $           (476,768) |
|                                                                                                                     |   |   |   |   |   |   |   |
| Weighted average number of common shares                                                                                 |   |   |   |   |   |   |
|    outstanding-basic and diluted                                                                          |            27,998,455 |   |            25,199,809 |   |            26,586,379 |   |            24,970,235 |
|                                                                                                                     |   |   |   |   |   |   |   |
| Loss per common share - basic and diluted                                                                                |  $                 (0.02) |   |  $                   0.00 |   |  $                 (0.05) |   |  $                 (0.02) |
|                                                                                                                     |   |   |   |   |   |   |   |
|                                                                                                                     |   |   |   |   |   |   |   |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                 |   |
|-------------------------------------------------------------------------------------------------|--------|
| CONSOLIDATED STATEMENTS OF CASH FLOWS                                                           |   |
|                                                                                            |   |   |   |   |   |
|                                                                                            |   | For the Nine Months Ended September 30, |   |
|                                                                                            |   | 2010 |   | 2009 |   |
| Cash Flows From Operating Activities:                                                           |   |   |   |   |   |
| Net loss                                                                                        |   |  $       (1,366,004) |   |  $          (476,768) |   |
| Adjustments to reconcile net loss to net                                                        |   |   |   |   |   |
|   cash used by operating activities:                                                       |   |   |   |   |   |
|     Depreciation                                                            |   |                  16,986 |   |                  16,986 |   |
|     Deferred compensation                                                   |   |                  13,333 |   |                (53,333) |   |
|     Issuance of common stock for consulting services                        |   |                324,500 |   |                166,000 |   |
|     Stock options                                                           |   |   |   |                    9,016 |   |
| Changes in assets and liabilities:                                                              |   |   |   |   |   |
|     Accounts receivable                                                     |   |                (19,500) |   |                  25,000 |   |
|     Inventory                                                               |   |                (12,648) |   |                (10,204) |   |
|     Accounts payable and accrued expenses                                   |   |                358,438 |   |                359,282 |   |
|                                                                                            |   |   |   |   |   |
| Net cash used in operating activities                                                           |   |              (684,895) |   |                  35,979 |   |
|                                                                                            |   |   |   |   |   |
| Cash Flows From Financing Activities:                                                           |   |   |   |   |   |
|    Repayments toward notes payable                                               |   |                (27,104) |   |                (24,903) |   |
|    Proceeds from sales of common stock                                           |   |                827,000 |   |                  95,000 |   |
|                                                                                            |   |   |   |   |   |
| Net cash provided by financing activities                                                       |   |                799,896 |   |                  70,097 |   |
|                                                                                            |   |   |   |   |   |
|     Net increase in cash and cash equivalents                               |   |                115,001 |   |                106,076 |   |
|                                                                                            |   |   |   |   |   |
|     Cash and cash equivalents, beginning of period                          |   |                  59,110 |   |                  31,910 |   |
|                                                                                            |   |   |   |   |   |
|     Cash and cash equivalents, end of period                                |   |  $            174,111 |   |  $            137,986 |   |
|                                                                                            |   |   |   |   |   |
| Supplemental Disclosures                                                                        |   |   |   |   |   |
|                                                                                            |   |   |   |   |   |
|     Cash paid during the year for interest                                  |   |  $                6,151 |   |  $                8,352 |   |
|     Cash paid during the year for taxes                                     |   |  $                       - |   |  $                       - |   |
|                                                                                            |   |   |   |   |   |
| Non-cash investing and financing activities:                                                    |   |   |   |   |   |
|     Common stock issued for services                                        |   |  $                       - |   |  $                9,016 |   |
|           Conversion of accrued salaries to equity |   |  $         1,739,000 |   |  $                       - |   |
|           Common stock options issued for services |   |  $                       - |   |  $                       - |   |
|     Common stock issued for consulting services                             |   |  $            345,500 |   |  $            166,000 |   |

----

----

----

----

|              Warrants  |  3,625,080  |
|----------------------------------------------------------------------------------------------|------------------|
|              Stock options  |  9,345,000  |
|                                                                                         |  12,970,080 |

----

| Notes payable to finance companies, due in monthly installments of $3,695, including principal and interest at prime plus .25%  collateralized by certain equipment |   $ |   81,288 |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|--------------------|
|                                                                                                                                                                          |          |               |
| Less current portion                                                                                                                                                          |          | (30,836)           |
|  Long term debt                                                                                                                                                          |  $       |  50,4528      |

----

----

----

----

|                        | NumberOutstanding |  Range of Exercise Price | NumberExercisable |
|-----------------------------|-------------------|-------------------------------|-------------------|
|                        |              |                          |              |
| Balance, June 30, 2010      | 6,427,367         | $0.60 - $9.00                 | 6,227,367         |
| Issued                      | -                 |                          | -                 |
|                        |              |                          |              |
| Balance, September 30, 2010 | 6,427,367         | $0.60-$9.00                   | 6,227,367         |

| ExercisePrice | Number Outstanding at September 30, 2010 | Weighted Average Remaining Contractual Life | Weighted Average Exercise Price | Number Exercisable at September 30, 2010 | Weighted Average Exercise Price |
|---------------|------------------------------------------|---------------------------------------------|---------------------------------|------------------------------------------|---------------------------------|
|          |                                     |                                        |                            |                                     |                            |
| 0.30          | 45,000                              | 3.25                                        | 0.30                            | 45,000                              | 0.30                            |
| 0.77          | 200,000                             | 4.25                                        | 0.77                            | 200,000                             | 0.77                            |
| 0.15          | 2,000,000                           | 4.25                                        | 0.15                            | 2,000,000                           | 0.15                            |
| 1.00          | 50,000                              | 3.00                                        | 1.00                            | 50,000                              | 1.00                            |
| 0.40     | 2,350,0004,645,000                       | 4.25                                        | 0.40                            | 2,350,0004,645,000                       | 0.40                       |

----

| Item 2.   | Management's Discussion and Analysis of Financial Condition and Results of Operations |
|---------------------|---------------------------------------------------------------------------------------|

----

----

----

| Item 3.   | Quantitative and Qualitative Disclosures About Market Risk |
|---------------------|------------------------------------------------------------|

----

| Item 4T.   | Controls and Procedures |
|----------------------|-------------------------|

----

|   | PART II.  OTHER INFORMATION |
|--------|---------------------------------------|

| Item 1.   | Legal Proceedings |
|---------------------|-------------------|

| Item 1A.   | Risk Factors |
|----------------------|--------------|

| Item 2.   | UnregisteredSales of Equity Securities and Use of Proceeds |
|---------------------|------------------------------------------------------------|

| Item 3.   | DefaultsUpon Senior Securities |
|---------------------|--------------------------------|

| Item 4.   | (Removed) |
|---------------------|-----------|

----

| Item 5.   | OtherInformation |
|---------------------|------------------|

| Item 6.   | Exhibits |
|---------------------|----------|

----

----